Literature DB >> 8815181

Tetrahydrobiopterin double-blind, crossover trial in Machado-Joseph disease.

T Sakai1, Y Antoku, T Matsuishi, H Iwashita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815181     DOI: 10.1016/0022-510x(95)00296-e

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological treatments of cerebellar ataxia.

Authors:  Masafumi Ogawa
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

2.  Therapeutic prospects for spinocerebellar ataxia type 2 and 3.

Authors:  Ilya Bezprozvanny; Thomas Klockgether
Journal:  Drugs Future       Date:  2009-12       Impact factor: 0.148

3.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 4.  Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.

Authors:  Benjamin R Underwood; David C Rubinsztein
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.